Funding Rounds
Octarine Bio

Octarine Bio Series A (2023, $4M)

Octarine Bio

Synthetic biology company producing superior cannabinoids for the pharmaceutical industry.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $4.65M

Raised Date: 2023-08-01

Investors